ABSTRACT
BACKGROUND: Dexmedetomidine provides smooth emergence with reduced agitation. The authors hypothesized low-dose dexmedetomidine infusion might contribute to hemodynamic stability during and after nasotracheal tube extubation. METHODS: Ninety-three adult patients scheduled for oral and maxillofacial surgery were enrolled in this prospective study. Patients were randomly assigned to receive normal saline (control group, nâ=â31), dexmedetomidine at 0.2âµg/kg/h (DEX0.2 group, nâ=â31), or dexmedetomidine at 0.4âµg/kg/h (DEX0.4 group, nâ=â31). Mean arterial pressure (MAP), heart rate (HR), and response entropy (RE) and state entropy (SE) were recorded during emergence from anesthesia. RESULTS: Extubation times were similar in the 3 groups. Mean MAP was significantly lower at eye opening (T3) and immediately after extubation (T4) in the DEX0.2 (Pâ=â.013 and .003, respectively) and DEX0.4 group (Pâ=â.003 and .027, respectively) than in the control group. At T3 and T4, mean HR was significantly higher in the control group than in the DEX0.2 (Pâ=â.014 and .022, respectively) or DEX0.4 groups (Pâ=â.003 and <.001, respectively). In the postanesthetic care unit, mean MAP and HR were significantly lower in the DEX0.2 (Pâ=â.03 and .022, respectively) and DEX0.4 groups (Pâ=â.027 and <.001, respectively) than in the control group. CONCLUSION: Intraoperative dexmedetomidine infusion at rates of 0.2 or 0.4âµg/kg/h during oral and maxillofacial surgery could provide stable hemodynamic profiles during anesthetic emergence from nasotracheal intubation without delaying extubation times.
Subject(s)
Dexmedetomidine/administration & dosage , Emergence Delirium/prevention & control , Hypnotics and Sedatives/administration & dosage , Intubation, Intratracheal/methods , Oral Surgical Procedures/methods , Adult , Blood Pressure , Dose-Response Relationship, Drug , Female , Heart Rate , Humans , Male , Middle Aged , Prospective StudiesABSTRACT
BACKGROUND: Citrullinemia type II is an autosomal recessive urea cycle disorder and a subtype of citrin deficiency. However, the management of recurrent hyperammonemia with neurologic symptoms in patients with citrullinemia type II is quite different from the management of other types of urea cycle disorders. In pats with citrullinemia type II, regional anesthesia might be a good choice for the early detection of hyperammonemic symptoms and addressing psychic stress. CASE PRESENTATION: A 48-year-old male with adult onset citrullinemia type II was scheduled for urethral scrotal fistula repair. During the first operation, spinal anesthesia with conscious sedation using dexmedetomidine was used, a second operation was performed after confirmation of infection control and a stable neurologic condition. In this patient, dietary planning with close monitoring of serum ammonia level and close observation of neurologic conditions might lead to successful perioperative care. CONCLUSION: For anesthesia of patients with adult onset citrullinemia type II, close monitoring of neurologic signs and serum ammonia are important to reduce neurologic complications induced by hyperammonemia. Regional anesthesia with a proper dietary plan might reduce patient stress and prevent metabolic tragedy.